FY2025 Earnings Estimate for ARWR Issued By B. Riley
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Stock analysts at B. Riley raised their FY2025 earnings per share estimates for Arrowhead Pharmaceuticals in a report issued on Thursday, February 13th. B. Riley analyst M. Mamtani now expects that the biotechnology company will post earnings of $1.15 per share for the year, up from their […]
